Find a Tender
complete
Official procurement procedure
SPECIMEN TRANSPORTERS
No classification published
Location not published
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Cardiff and Vale University Health Board: "SPECIMEN TRANSPORTERS ". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Cardiff and Vale University Health Board | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Cardiff and Vale University Health Board
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Cardiff and Vale University Health Board. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
3.3Bids / Report
Supplier ConcentrationModerate Concentration
Cardiff CouncilTop vendor: 32.1% of attributable valuePayment Terms
Check noticePublished terms
Coverage: 44 active published awards; 3 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
| Supplier Name | Historic Awards | Attributable GBP Value |
|---|---|---|
| Cardiff Council | 3 wins | £167,962 |
| Vale of Glamorgan Council | 2 wins | £105,800 |
| Northstar Healthcare Consultancy Ltd | 1 win | £93,000 |
| Mel Research | 1 win | £81,600 |
| Cardiff Marriott Hotel | 1 win | £43,516 |
Procedure terms
Contracting AuthorityCardiff and Vale University Health Board | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published27 Mar 2026, 14:21 GMT | Last source update27 Mar 2026, 14:21 GMT | Recurring procurementNot published |
ClassificationNot published | ||
Delivery areaLocation not published | ||
OCIDocds-h6vhtk-064acc | ||
What is being bought
WEQAS require a specialist packaging solution to
distribute External Quality Assessment (EQA)
material to more than 35,000 sites globally each
month. The packaging must provide a compliant,
leak-proof secondary containment for Exempt and
Category B Biological Specimens, using sustainable
materials where possible.
What changed
From the official release history
- Official notice release published
27 Mar 2026, 14:21 GMT - Official notice release published
10 Feb 2026, 14:58 GMT - Status changed to complete
9 Feb 2026, 09:34 GMT - Official notice release published
9 Feb 2026, 09:34 GMT - Buyer information updated
9 Feb 2026, 09:34 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
27 Mar 2026, 14:21 GMT - Award active
Not published · Not published - Contract active
Signed 17 Mar 2026, 00:00 GMT · £436,583
Commercial outcome and competition
Awards MEDDX Solutions limited Not published · Not published · active |
Contracts Specimen Transporters £436,583 · signed 17 Mar 2026, 00:00 GMT · active Contract period: 23 Mar 2026, 00:00 GMT — 22 Mar 2028, 23:59 GMT |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
Cardiff and Vale University Health Board
Contracting authority GB-PPON-PPPR-7969-BTJGDocuments (1)
Official links; attachments are not copied
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleThe direct award justification applies as the current supplier has historically supplied the specialist specimen transporters and associated packaging products required for the WEQAS service. The products supplied are bespoke and designed specifically to meet WEQAS operational requirements, including unique vial sizes, transport combinations and international biological specimen transport regulations. The transporters incorporate patented leak-proof clamshell technology with integrated absorbent material and are manufactured to meet IATA transport compliance standards. These specifications are essential to ensure the safe and compliant transport of External Quality Assessment materials distributed globally. The products supplied are bespoke to WEQAS and have been developed and refined over a number of years to meet specific operational and regulatory requirements. Replicating this design and manufacturing process with an alternative supplier would present significant technical, regulatory and operational risks, including potential disruption to service delivery. Continuity of supply is critical as WEQAS distributes over 35,000 EQA consignments per month worldwide. Any disruption to packaging supply would impact international distribution and service delivery. Previous market engagement indicated that no alternative suppliers were able to meet the required specification or provide a cost-effective equivalent within operational timescales. For these reasons, the direct award is considered justified due to technical reasons, absence of competition, and the requirement for bespoke specialist products essential for service continuity. |